140 related articles for article (PubMed ID: 3700039)
1. Novantrone for childhood malignant solid tumors. A pediatric oncology group phase II study.
Pratt CB; Vietti TJ; Etcubanas E; Sexauer C; Krance RA; Mahoney DH; Patterson RB
Invest New Drugs; 1986; 4(1):43-8. PubMed ID: 3700039
[TBL] [Abstract][Full Text] [Related]
2. An EORTC phase II study of mitoxantrone in solid tumors and lymphomas.
De Jager R; Cappelaere P; Armand JP; Keiling R; Fargeot P; Bastit P; van Glabbeke M; Renard J; Earl H; Rubens R
Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1369-75. PubMed ID: 6542006
[TBL] [Abstract][Full Text] [Related]
3. [A phase II study of mitoxantrone in refractory and relapsed malignant lymphomas. Cooperative Study Group of Mitoxantrone in Malignant Lymphomas].
Kimura I; Ohnoshi T; Ogawa M; Sampi K; Masaoka T; Yamada K; Ohta K; Kitani T; Kawagoe H; Shirakawa S
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2800-6. PubMed ID: 3753026
[TBL] [Abstract][Full Text] [Related]
4. A phase II study of dihydroxyanthracenedione (DHAD, mitoxantrone, NSC 301739) in advanced malignant melanoma.
Arseneau JC; Schoenfeld DA; Borden EC
Invest New Drugs; 1986; 4(1):53-6. PubMed ID: 3700041
[TBL] [Abstract][Full Text] [Related]
5. Phase I trial of mitoxantrone in children.
Ungerleider RS; Pratt CB; Vietti TJ; Holcenberg JS; Kamen BA; Glaubiger DL; Cohen LF
Cancer Treat Rep; 1985 Apr; 69(4):403-7. PubMed ID: 3857968
[TBL] [Abstract][Full Text] [Related]
6. Mitoxantrone in malignant lymphoma.
Gams RA; Bryan S; Dukart G; Weiss A; Case D; Jones S; Stein R
Invest New Drugs; 1985; 3(2):219-22. PubMed ID: 4019123
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial of doxorubicin, mitoxantrone and bisantrene in advanced breast cancer (a South West Oncology Group Study).
Cowan JD; Osborne CK; Neidhart JA; Von Hoff DD; Constanzi JJ; Vaughn CB
Invest New Drugs; 1985; 3(2):149-52. PubMed ID: 3894277
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino 9,10-anthracenedione dihydrochloride)(NSC 301739, DHAD) in patients with metastatic malignant melanoma. A Southwest Oncology Group pilot.
Taylor SA; Tranum BT; Von Hoff DD; Costanzi JJ
Invest New Drugs; 1985; 3(1):67-9. PubMed ID: 3988458
[TBL] [Abstract][Full Text] [Related]
9. Mitoxantrone as first-line chemotherapy in advanced breast cancer: results of a collaborative European study.
Mouridsen HT; Cornbleet M; Stuart-Harris R; Smith I; Coleman R; Rubens R; McDonald M; Rainer H; van Oosterom A; Smyth J
Invest New Drugs; 1985; 3(2):139-48. PubMed ID: 4019118
[TBL] [Abstract][Full Text] [Related]
10. Mitoxantrone: a phase II study in the treatment of patients with advanced breast carcinoma and other solid tumours.
Stuart-Harris RC; Smith IE
Cancer Chemother Pharmacol; 1982; 8(2):179-82. PubMed ID: 7105382
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of mitoxantrone in advanced sarcomas: a Southwest Oncology Group study.
Bull FE; Von Hoff DD; Balcerzak SP; Stephens RL; Panettiere FJ
Cancer Treat Rep; 1985 Feb; 69(2):231-3. PubMed ID: 3882233
[No Abstract] [Full Text] [Related]
12. Phase I study of mitoxantrone on a daily X 5 schedule.
Goldsmith MA; Ohnuma T; Jaffrey IH; Greenspan EM; Holland JF
Am J Clin Oncol; 1984 Oct; 7(5):567-70. PubMed ID: 6507380
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study.
Blaney SM; Needle MN; Gillespie A; Sato JK; Reaman GH; Berg SL; Adamson PC; Krailo MD; Bleyer WA; Poplack DG; Balis FM
Clin Cancer Res; 1998 Feb; 4(2):357-60. PubMed ID: 9516923
[TBL] [Abstract][Full Text] [Related]
14. [Phase II study of mitoxantrone].
Tada A; Ogawa M; Usui N; Inagaki J; Horikoshi N; Inoue K; Ikeda K; Adachi K; Nakada H; Okada Y
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1649-54. PubMed ID: 6476838
[TBL] [Abstract][Full Text] [Related]
15. Mitoxantrone in advanced breast cancer--a phase II study with special attention to cardiotoxicity.
Coleman RE; Maisey MN; Knight RK; Rubens RD
Eur J Cancer Clin Oncol; 1984 Jun; 20(6):771-6. PubMed ID: 6540179
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial comparing mitoxantrone with doxorubicin in patients with stage IV breast cancer.
Allegra JC; Woodcock T; Woolf S; Henderson IC; Bryan S; Reisman A; Dukart G
Invest New Drugs; 1985; 3(2):153-61. PubMed ID: 3894278
[TBL] [Abstract][Full Text] [Related]
17. Mitoxantrone in advanced breast cancer: a phase II trial of the Southwest Oncology Group.
Knight WA; Von Hoff DD; Neidhart JA; Tranum BL; Fabian C; Jones SE
Invest New Drugs; 1983; 1(2):181-4. PubMed ID: 6678866
[TBL] [Abstract][Full Text] [Related]
18. Mitoxantrone in malignant melanoma.
Presant CA; Gams R; Bartolucci A
Cancer Treat Rep; 1984 Jun; 68(6):903-5. PubMed ID: 6733704
[TBL] [Abstract][Full Text] [Related]
19. Phase II studies of mitoxantrone in patients with primary liver cancer.
Falkson G; Coetzer BJ
Invest New Drugs; 1985; 3(2):187-9. PubMed ID: 4019121
[TBL] [Abstract][Full Text] [Related]
20. Mitoxantrone as a first-line treatment of advanced breast cancer.
Landys K; Borgstrom S; Andersson T; Noppa H
Invest New Drugs; 1985; 3(2):133-7. PubMed ID: 4019117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
